Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Enquist ORL AB
AB
Active
Org 5590204524
Tomtebogatan 21 A Lgh 1403
Medical specialists activities · NACE 8622
Est. 2015
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 286K
+14% vs 2023
EBITDA margin
76.2%
+22% vs 2023
Equity ratio
63.3%
Financial strength
Net profit 2024
SEK 173K
+23% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 286K
+14%
EBITDA
SEK 218K
+22%
Net profit
SEK 173K
+23%
Total assets
SEK 357K
+23%
Equity
SEK 226K
+17%
Employees
0
—
Company information
Legal name
Enquist ORL AB
Org number
5590204524
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
10 juli 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utföra läkartjänster som Öron-Näsa-Hals specialist.
Contact
Address
Tomtebogatan 21 A Lgh 1403
Email
elisabet@enquist.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
122
0
166
250
286
Staff expenses
—
—
—
—
—
EBITDA
46
−45
107
179
218
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
46
−45
107
179
218
Net financials
—
—
—
—
1
Profit before tax
46
−45
108
179
219
Tax
−11
−0
−16
−38
−46
Net profit
35
−45
92
141
173
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
315
50
183
290
357
Equity
245
50
142
193
226
Long-term debt
0
0
0
0
0
Short-term debt
70
0
41
97
131
Total debt
70
—
41
97
131
Financial ratios
5-year trend
EBITDA margin
76.2%
This company
15.8%
Market median
+382% vs market
2020
2024
Equity ratio
63.3%
This company
38.2%
Market median
+66% vs market
2020
2024
Return on equity
76.5%
This company
18.4%
Market median
+316% vs market
2020
2024
Net profit margin
60.5%
This company
8.1%
Market median
+647% vs market
2020
2024
Asset turnover
0.80×
This company
1.12×
Market median
-29% vs market
2020
2024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
GM
Gertrud Maria Elisabet Enquist
Board of Directors
2022
FS
Fredrik Sebastian Rye
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Enquist ORL AB also hold positions in
0
other companies.
Person
Role here
Other companies
Gertrud Maria Elisabet Enquist
Board of Directors
0 companies
Fredrik Sebastian Rye
Deputy Board Member
0 companies